SCHEMBL13484137

SCHEMBL13484137

COc1cnc(-n2ccc(CO)n2)c2[nH]cc(C(=O)C(=O)N3CCN(C(=O)c4ccccc4)CC3)c12

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 6/20 0.74
CYP2C9 P11712 5/20 0.74
CYP2D6 P10635 5/20 0.74
CYP3A4 P08684 3/20 0.74
CYP1A2 P05177 2/20 0.74
CYP2C8 P10632 1/20 0.74
CYP2B6 P20813 1/20 0.74
KCNH2 Q12809 1/20 0.74
ALDH1A1 P00352 4/20 0.38
TSHR P16473 2/20 0.37
BTK Q06187 1/20 0.35
ABL1 P00519 1/20 0.35
BCR P11274 1/20 0.35
DRD2 P14416 1/20 0.35
HTR2A P28223 1/20 0.35
DRD3 P35462 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
HSD17B10 Q99714 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2629146 0.94 CYP2C19 (0.71) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL16592126 0.94 CYP2C19 (0.72) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL1763036 0.92 CYP2C19 (0.73) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL1763918 0.92 CYP2C19 (0.70) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL6421424 0.92 CYP2C19 (0.68) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL1762968 0.92 CYP2C19 (0.69) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL2629157 0.91 CYP3A4 (0.68) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL1763652 0.91 CYP2C19 (0.68) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL1763161 0.90 CYP2C19 (0.79) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2
SCHEMBL2629148 0.90 CYP2C19 (0.77) CYP2C19CYP2C9CYP2D6CYP3A4CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662823-B2 Pharmaceutical formulations of substituted azaindoleoxoacetic piperazine derivatives BRISTOL-MYERS SQUIBB COMPANY (US) 2010-02-16 US disclosed